Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?-Reference-Cited by-同舟云学术

Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?

Published:2019-09 Issue: Volume:37 Page:100579
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Margelidon-Cozzolino Victor,Delavenne Xavier,Catella-Chatron Judith,De Magalhaes Elodie,Bezzeghoud Souad,Humbert Marc,Montani David,Bertoletti Laurent

Funder

Fonds de Recherche en Santé Respiratoire

Fondation du Souffle

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference72 articles.

1. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS);Galiè;Endor Eur Respir J,2015

2. Pulmonary arterial hypertension;Montani;Orphanet J Rare Dis,2013

3. Current practice for pulmonary hypertension;Satoh;Chin Med J (Engl),2014

4. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort;Strange;Heart,2012

5. Pulmonary arterial hypertension in France: results from a national registry;Humbert;Am J Respir Crit Care Med,2006

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct oral anticoagulants in the treatment of chronic thromboembolic pulmonary hypertension patients: A retrospective cohort study;Respiratory Medicine;2024-09

2. Echocardiographic Hemodynamics Correlate with Differences in DOAC-specific Bleeding and Stroke Rates in Non-Valvular Atrial Fibrillation;2024-08-26

3. Safety and Outcomes with Direct Oral Anticoagulants Versus Vitamin-K Antagonists in Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review, Meta-Analysis, and Meta-Regression;Cardiology in Review;2024-06-04

4. Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension;Thrombosis Research;2023-09

5. Management of Pulmonary Arterial Hypertension;Seminars in Respiratory and Critical Care Medicine;2023-06-27